Per Genervon, what is the position of the patient community?
The ALS Association, appreciates the statement that the FDA released today calling on Genervon “to release all the data from the company’s recently completed trial in order to allow a more informed discussion of the trial findings among ALS stakeholders.”
Stand by for more on this on-going debate.